What is the recommended dose ratio for IGF-1 LR3 and follistatin-344 in research protocols? Research protocols typically employ 80 mcg IGF-1 LR3 administered daily via subcutaneous injection, paired with 200 mcg follistatin-344 every 3 days
1 This led researchers to further investigate the link between gastric hormones and insulin release
Rate of Weight Loss The goal of weight loss should be steady and sustainable rather than instant. If an individual is seeing excellent results at a mid-level dose, like 1.0 mg, and is not experiencing hunger, a provider may decide there is no immediate need to increase to the 2.4 mg level
Did you expect such developments
In March 2024, following the results of the SELECT study, the U.S
Ligand binding triggers receptor autophosphorylation and recruitment of insulin receptor substrate (IRS-1, IRS-2) and Shc adapter proteins, activating the PI3KAktmTOR and RasRafMEKERK signaling cascades